NOTIFIABLE. Infectious Disease Assessment for Migrants RECOMMENDATIONS. Offer test (HBsAg and anti-hbc) to: Vaccinate:
|
|
- Wendy Houston
- 1 years ago
- Views:
Transcription
1 5.2 Hepatitis B NOTIFIABLE RECOMMENDATIONS Offer test (HBsAg and anti-hbc) to: = All new migrants originating from countries with a HBsAg prevalence of 2% = Household and sexual of identified acute or chronic cases = All women attending antenatal services = Sex workers and those who have been trafficked = People who inject drugs (PWID) = Men who have sex with men (MSM) Vaccinate: = All infants according to the routine childhood immunisation schedule, 6 in 1 at 2, 4 and 6 months = All children aged 12 months to <10 years according to the late entrants catch-up schedule Vaccinate if non-immune (vaccination not required if anti-hbc positive): = All migrants originating from countries with a prevalence of 2% = Children born to parents from countries with a prevalence of 2% = Persons at risk of occupational exposure to blood or blood contaminated environments = Household and sexual of persons with acute or chronic infection = Families adopting/fostering children from countries with a prevalence of 2% = Babies born to mothers who have HBV infection (they should receive a complete course of vaccine at 0, 2, 4 and 6 months and also HBIG within 24 hours of birth and have serological testing 2 months after vaccination completed) = HIV exposed and HIV infected infants should be given hepatitis B vaccine at birth and then continue with the routine childhood schedule = Sex workers and those who have been trafficked = Those deemed at risk following an assessment of their health needs = PWID and their = MSM Refer all HBsAg positive cases to specialist services for review. People who are HBsAg negative, anti-hbc positive should be referred for specialist care if they become immunosuppressed (including that due to chemotherapy or transplantation). Hepatitis B virus is an important cause of serious liver disease including acute and chronic hepatitis, cirrhosis and liver cancer. The virus is transmitted by infected blood or body fluids. Transmission mainly occurs by sexual contact with an infected person, from an infected mother to her baby around the time of birth or horizontal transmission in early childhood, sharing of needles and other drug paraphernalia by people who inject drugs (PWID), and accidental sharps injuries. (1)
2 Epidemiology WHO has categorised countries based upon the prevalence of hepatitis B surface antigen (HBsAg) into: (2) = High endemicity ( 8%): Sub-Saharan Africa, South-East Asia, the Eastern Mediterranean countries, South and Western Pacific Islands, the interior of the Amazon basin and the Caribbean. HSE/hpsc = Intermediate endemicity (2-7%): South-Central and South-West Asia, Eastern and Southern Europe, the Russian Federation and most of central and South America. = Low endemicity (<2%): Australia, New Zealand, Northern and Western Europe, and North America. (Figure 5.2.1) Figure Geographic distribution of HBV endemicity Source: Centers for Disease Control and Prevention. CDC Information for International Travel 2012, New York: Oxford University Press; 2012 There are >350 million people chronically infected worldwide. Hepatitis B is times more infectious than HIV. Chronic HBV infection develops in 90% of those infected as infants and 1-10% infected as adults. Premature death from liver disease occurs in 15-25% of chronically infected people. In Ireland, 91% of cases notified between 2004 and 2013 were chronically infected. There were 5,915 notifications of cases of chronic hepatitis B in this time period (annual average: n=592) with a peak in 2008 (n=772). (3) Available data indicate that most cases of chronic hepatitis B were born and infected outside of Ireland, mostly in Sub-Saharan Africa, Asia, Central and Eastern Europe. It is likely that most became infected at birth or in early childhood and they have been infected for decades. Trends in chronic cases are heavily influenced by trends in immigration to Ireland
3 Number of notifications Year Acute Chronic Unknown Figure Number of hepatitis B notifications by acute/chronic status, Source: HPSC Annual Epidemiological Report Hepatitis B chapter. Available from: (3) Rationale for assessment Hepatitis B is a condition with often debilitating consequences. However, it is vaccine preventable, there are simple tests available for diagnosis and there are effective treatments available to improve the outcome of infection. The following are the main points behind the rationale for assessing migrants for hepatitis B. = There is a high probability of developing chronic infection if hepatitis B is acquired in infancy (approx. 90%) and when aged under 5 years (approx. 30%). (1) = Between 15 and 40% of people with chronic infection develop cirrhosis, liver failure or hepatocellular carcinoma. (1) = Hepatitis B is a vaccine preventable disease; therefore those identified as non-immune can be offered vaccination to prevent infection. (2) = For those identified with infection, specialist services and treatments are available to improve disease prognosis and prevent ongoing spread. (1) Assessment The SAC sub-committee endorses the following recommendations of hepatitis B assessment from Public England Migrant Guide for the assessment of hepatitis B in migrants and the National Immunisation Advisory Committee (NIAC). (2,4) Hepatitis B assessment should be offered to: = All migrants from areas of high and intermediate endemicity, that is, from a country with a prevalence of HBsAg of greater than or equal to 2%. This includes countries in Sub-Saharan Africa, Asia, Eastern Mediterranean region, Eastern and Southern Europe, Central and South America, the Caribbean and South and West Pacific Islands. = Contact tracing is recommended for household and sexual of acute and chronic cases and vaccine offered to those who are not immune. In addition it is recommended that: = All women who attend for antenatal services should have their hepatitis B status assessed. Blood should be taken for hepatitis B surface antigen (HBsAg) and anti-hepatitis B core antigen (anti HBc). A guide to the interpretation of serological results is shown in table
4 Table A guide to interpretation of hepatitis B serological markers HBsAg HBeAg Anti-HBe Anti-HBc IgM Total anti- HBc Anti-HBs Interpretation Action HSE/hpsc Negative Negative Negative Negative Negative Negative Susceptible to HBV HBV vaccine if infant or member of at risk group^ Positive Positive Negative Pos/Neg Pos/Neg Negative Acute HBV infection Seek immediate specialist advice if clinically unwell Refer for specialist review Negative Negative Negative Positive Positive* Negative Recent HBV infection (HBsAg window) Positive Positive Negative Weak Pos/ Neg Positive Negative Pos/Neg Weak Pos/ Neg Positive Negative Chronic HBV infection** Positive Negative HBeAg neg chronic infection*** Refer for specialist review Refer for specialist review Negative Negative Pos/Neg Negative Positive Pos/Neg Past HBV infection Negative Negative Negative Negative Negative Positive Response to HBV vaccine Should be referred for specialist care if they become immunosuppressed No action required ^ See targeted immunisation programme below for at risk groups *Anti-HBc detected in 2 assays **Follow-up sample required to confirm chronic HBV infection ***Follow-up sample required and also HBV DNA viral investigations may be required Infection can reactivate in the case of immunosuppression, chemotherapy, transplantation Source: Adapted from EMI Guidelines Appendix 10 Interpretation of HBV results (5)
5 Vaccination In 2008, universal infant hepatitis B virus (HBV) vaccination was introduced in Ireland. This runs in parallel with the pre-existing targeted immunisation programme for those individuals who are at increased risk of HBV because of their occupation, lifestyle or other factors (e.g. close contact with a case or carrier). The following recommendations on hepatitis B vaccination are from the Immunisation Guidelines for Ireland (2) Universal immunisation All infants should be offered HBV vaccine as part of the routine childhood immunisation schedule (6 in 1) at 2, 4 and 6 months. Targeted immunisation programme The following groups are at increased risk of HBV infection and should receive HBV vaccine if non-immune: = Immigrants from areas with a high or intermediate prevalence of HBV. = Children born to parents from high or intermediate prevalence of HBV. = Persons with occupational exposure to blood or blood-contaminated environments. = Family and household. The spouses, sexual partners, family and household of acute cases and individuals with chronic infection. Where testing for markers of current or past infection is clinically indicated, this should be done at the same time as the administration of the first dose. Vaccination should not be delayed while waiting for results of the tests. Further doses may not be required in those with clear evidence of past exposure. = Families adopting or fostering children from countries with a high or intermediate prevalence of hepatitis B. These children should be tested for evidence of current or past hepatitis B infection and the household offered immunisation if required, preferably before adoption/fostering. If the status of the child is unknown these families should be recommended vaccination. = Babies born to mothers who are HBV infected (HBsAg positive). Perinatal transmission of HBV infection can be prevented in approximately 95% of infants born to HBsAg positive mothers by early active and passive immunoprophylaxis of the infant. Routine screening of all antenatal patients for HBsAg is essential for identifying women whose infants will require post-exposure immunoprophylaxis beginning at birth. All babies born to these mothers should receive a complete course of vaccine at 0, 2, 4 and 6 months and also hepatitis B specific immunoglobulin (HBIG) within 24 hours of birth. The doses at 2, 4 and 6 months may be given as the routine 6 in 1. Following the administration of HBIG and the first dose of vaccine, arrangements should be made to follow up the child for serological assessment and subsequent doses of vaccine. Infants born to mothers who are HBV infected should be tested 2 months after completing HBV immunisation to determine HBV status and postvaccination response. = HIV exposed and HIV infected infants should be given hepatitis B vaccine at birth and then continue with the routine childhood schedule. = Those deemed at risk following an assessment of their health needs. = People who inject drugs (PWID) and their = Men who have sex with men (MSM) = Sex workers including those that have been trafficked Hepatitis B specific immunoglobulin (HBIG) is available for passive protection and, when indicated, is normally used in combination with hepatitis B vaccine to confer passive/active immunity after exposure. It should be administered according to the manufacturer s guidelines and should ideally be given within 48 hours of exposure but not later than a week after exposure. HBIG provides short-term protection (3-6 months). (2) Post-vaccination serological testing Routine post-vaccination testing for hepatitis B surface antibodies (anti-hbs) is recommended 2 months after completing the course of vaccination for persons who are at continuing risk of HBV exposure, e.g. healthcare workers, sexual partners of HBsAg positive persons. This does not apply to children receiving routine childhood immunisation with hepatitis B vaccine. Following primary vaccination, it is preferable to achieve anti-hbs levels greater than 100 miu/ml, although levels greater than 10 miu/ml are generally accepted as protecting against infection. Anti-HBs titre often declines post-vaccination but a rapid anamnestic response develops after exposure to the virus
6 References (1) Heymann D. Control of communicable diseases manual. 19th ed. Washington: American Public health Association; (2) National Immunisation Advisory Committee. Immunisation Guidelines for Ireland Available from: (3) HPSC. Annual Epidemiological Report 2013 [Internet]. Chapter 5.1 Hepatitis B. Dublin: Available from: (4) Public England. Migrant Guide Hepatitis B. [Internet] Available from: (5) HPSC. EMI Toolkit - Guidelines for the Emergency Management of Injuries [Internet] Available from: HSE/hpsc
EPIDEMIOLOGY OF HEPATITIS B IN IRELAND
EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis
William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016
William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15
Universal Hepatitis B Vaccination in Ireland - Why now?
Universal Hepatitis B Vaccination in Ireland - Why now? Dr Lelia Thornton April 2008 Background Introduction Epidemiology in Ireland Ireland vs Europe Economic evaluation New schedule Hepatitis B virus
Executive summary of recommendations
MOH CLINICAL PRACTICE GUIDELINES 2/2011 Chronic Hepatitis B Infection College of Family Physicians, Singapore Academy of Medicine, Singapore Singapore Medical Association Executive summary of recommendations
Epidemiology It is estimated that there are at least 350 million chronically infected cases of HBV worldwide. (see Figure 9.1).
Chapter 9 09 Vaccine introduced to primary schedule 2008 NOTIFIABLE In some circumstances, advice in these guidelines may differ from that in the Summary of Product Characteristics of the vaccines. When
TESTING AND MANAGEMENT. Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL
TESTING AND MANAGEMENT Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL Disclosure and acknowledgments No conflicts of interest Board Member of Hepatitis
2015 Outpatient Chronic Hepatitis B Management
2015 Outpatient Chronic Hepatitis B Management Hepatitis B Hepatitis B Info 70% of acute infections are subclinical More severe symptoms when in addition to other liver disease Fulminant Hepatitis
Hepatitis B Virus (Pregnancy) Investigation Guideline
Hepatitis B Virus (Pregnancy) Investigation Guideline Contents CASE DEFINITION... 3 LABORATORY ANALYSIS... 3 BACKGROUND... 4 NOTIFICATION TO PUBLIC HEALTH... 5 INVESTIGATOR RESPONSIBILITIES... 6 STANDARD
When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)
XI. OCCUPATIONAL EXPOSURES TO HEPATITIS B AND C RECOMMENDATION: When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) The risk of transmission
HEPATITIS B The Importance of the Hepatitis B Vaccine
HEPATITIS B The Importance of the Hepatitis B Vaccine Since 1982, a hepatitis B vaccine has been available to prevent hepatitis B virus infection. Today, the vaccine is made using recombinant DNA technology
Hepatitis Vaccination Policy
Hepatitis Vaccination Policy Purpose To outline requirements for Hepatitis Vaccinations Scope All operational levels of Life Saving Victoria Policy Background Hepatitis is a highly infectious disease.
Document title: Hepatitis B Neonatal and Infant Protocols. Verified by: Matthew Dominey, Screening and Immunisation Manager
South West PHE Screening and Immunisation Team Good Practice Guidance for the management of the NHS Hepatitis B Neonatal and Infant Immunisation Programme Document title: Hepatitis B Neonatal and Infant
Are Booster Doses of Hepatitis B Vaccine Necessary?
Are Booster Doses of Hepatitis B Vaccine Necessary? Current CDC Recommendations And Gaps in Knowledge Division of Viral Hepatitis Centers for Disease Control and Prevention, USA Current United States Recommendations
Infection reports. Acute hepatitis B (England): annual report for Immunisation
Infection reports Volume 8 Number 33 Published on: 22 August 2014 Immunisation Acute hepatitis B (England): annual report for 2013 Introduction Hepatitis B is a blood borne infection of the liver caused
ALGORITHM FOR SUSPECTED ACUTE VIRAL HEPATITIS
SEROLOGICAL TESTING FOR SUSPECTED VIRAL HEPATITIS Summary of the Clinical Practice Guideline January 2006 ALGORITHM FOR SUSPECTED ACUTE VIRAL HEPATITIS These recommendations are systematically developed
ROYAL HOSPITAL FOR WOMEN
HEPATITIS B POSITIVE MOTHERS AND THEIR BABIES This LOP is developed to guide clinical practice at the Royal Hospital for Women. Individual patient circumstances may mean that practice diverges from this
Transmissible Major Viral Infections Practice Standard. Including Introduction
Transmissible Major Viral Infections Practice Standard Including Introduction 1 Foreword Standards Framework for Oral Health Practitioners The Dental Council ( the Council ) is legally required to set
Bloodborne Pathogens. Safety Guidelines
Bloodborne Pathogens Safety Guidelines What are bloodborne pathogens? o Bloodborne pathogens are infectious materials in blood, and other body fluids, that can cause disease in humans. o Hepatitis B virus
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
NHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups
NHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups Approved 01/04/2012 Version 1.0 Date of First Issue 01/04/2012 Review Date 01/02/2014 Date of Issue 01/04/2012 EQIA Yes Author
Series of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)
UTAH PREVENTIVE CARE RECOMMENDATIONS Adult - Ages 19 and Above IMMUNIZATIONS CONTENTS: General Instructions Hepatitis A Hepatitis B Human Papilloma Virus Influenza Meningococcal A, C, Y, W (MCV4) Meningococcal
Viral Hepatitis Case Report
Page 1 of 9 Viral Hepatitis Case Report Perinatal Hepatitis B Virus Infection Michigan Department of Community Health Communicable Disease Division Investigation Information Investigation ID Onset Date
Viral hepatitis. Report by the Secretariat
SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/15 Provisional agenda item 11.12 25 March 2010 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses (hepatitis A, B, C, D and
Screening for Bloodborne. Unit. A Sarabia MD
Screening for Bloodborne Pathogens in the Hemodialysis Unit A Sarabia MD Objectives To review the rationale for bloodborne pathogen screening To review relevant characteristics of bloodborne pathogen infections:
Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice
Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice Dr Chris Ford GP & SMMGP Clinical Lead Kate Halliday Telford & Wrekin Shared Care Coordinator Aims Discuss:
Appendix 3 Exposure Incident Report Form
Appendix 3 Exposure Incident Report Form January, 2015 Page 1 of 6 Please see the following pages for the Exposure Incident Report Form. Guidelines for the Management of Exposure to Blood and Body Fluids
Hepatitis B. Vaccination
Hepatitis B Vaccination This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and
english facts about hepatitis A, B and C
english facts about hepatitis A, B and C What is hepatitis? Hepatitis means inflammation of the liver. Many viruses can cause liver inflammation, including the hepatitis A, B and C viruses. Some people
Hepatitis B : A Clinical Perspective
Hepatitis B Overview Hepatitis B : A Clinical Perspective Adapted by Jill Gallin, CPNP Assistant Professor of Clinical Nursing Serious: Causes death from liver disease in up to 25% of those infected at
Viral Hepatitis A, B, and C
Viral Hepatitis A, B, and C What is Hepatitis? Hepatitis means inflammation of the liver Elizabeth A. Bancroft, MD, SM Acute Communicable Disease Control County of Los Angeles Department of Public Health
Guidance for hepatitis A and B vaccination of drug users in primary care and criteria for audit
Royal College of General Practitioners Guidance for hepatitis A and B vaccination of drug users in primary care and criteria for audit RCGP Drug Misuse Training Programme RCGP Sex, Drugs and HIV Task Group
Indicate whether the case had jaundice. If not known or unavailable then select the Unknown option.
HBC-1 HEPATITIS B, C, NOS Disease name Disease Indicate whether the case is hepatitis B, C or NOS (Not Otherwise Specified). Select hepatitis NOS for cases of hepatitis D, hepatitis E or if the type of
12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS
HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should
Hepatitis B in Pregnancy
Hepatitis B in Pregnancy This guideline was updated in July 2015 by Dr Joana de Sousa, with input from members of the New Zealand Maternal Fetal Medicine Network and Neonatology. Background It is recognised
New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy
New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy Policy Statement The accelerated four-dose schedule for combined hepatitis A and B vaccine
Communicable Disease Control Chapter I - Management of Specific Diseases Hepatitis B September 2009 TABLE OF CONTENTS
TABLE OF CONTENTS 1.0 GOAL...1 2.0 CLINICAL DESCRIPTION...1 3.0 EPIDEMIOLOGY...2 4.0 LABORATORY INFORMATION...2 5.0 DEFINITIONS...2 6.0 CASE MANAGEMENT...5 7.0 CONTACT MANAGEMENT...5 8.0 HEPATITIS B POST-
Perinatal Hepatitis B
Perinatal Hepatitis B MISTY HALL RN, BSN NURSE CONSULTANT AK IMMUNIZATION PROGRAM Perinatal Case Management Importance of Birth Dose to End Hepatitis B in Newborns was addressed yesterday Goals: Identify
Patient Group Direction for the Administration of Hepatitis B vaccine
Patient Group Direction for the Administration of Hepatitis B vaccine This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for Immunisations), which details information
HBC-1. If the case had jaundice, tick the Yes box. If not, tick the No box. If not known or unavailable then tick the Unknown box.
HBC-1 HEPATITIS B, C, NOS Disease Name Disease Indicate whether the case is hepatitis B, C or NOS (Not Otherwise Specified). Use NOS for cases of hepatitis D or E or if the type of hepatitis has not been
Appendix B: Provincial Case Definitions for Reportable Diseases
Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Hepatitis B Revised Hepatitis B 1.0 Provincial Reporting Confirmed, chronic and probable cases of disease
GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES
GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES Hepatitis B, Hepatitis C and HIV may be contracted through exposure to any body fluid, particularly blood. Follow up
UCSF Communicable Disease Surveillance and Vaccination Policy
Office of Origin: Occupational Health Program I. PURPOSE To provide a sustainable, healthy and safe working environment for UCSF research laboratory staff, and animal research care staff and to prevent
GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT
GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT January 2005 Guidelines for Viral Hepatitis Surveillance and Case Management Ordering information To order a copy of this manual, write to:
Hepatitis B. Section 1: ABOUT THE DISEASE. A. Etiologic Agent. B. Clinical Description. C. Vectors and Reservoirs. D. Modes of Transmission
A. Etiologic Agent Section 1: ABOUT THE DISEASE Hepatitis B The hepatitis B virus (HBV) is a DNA hepadnavirus. Important components of the viral particle include hepatitis B surface antigen (HBsAg), hepatitis
Hepatitis B (Chronic Carrier)
January 2011 Hepatitis B (Chronic Carrier) Case Definition Confirmed Chronic Carrier Laboratory confirmation of infection: Persistence of confirmed Hepatitis B surface antigen (HBsAg) positivity for more
The Epidemiology of Hepatitis A, B, and C
The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago jberkes@uic.edu Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations
FREQUENTLY ASKED QUESTIONS ON PENTAVALENT
FREQUENTLY ASKED QUESTIONS ON PENTAVALENT 1 Frequently asked questions on Pentavalent Two additional vaccines have been added to the DPT vaccine, namely total of 5 vaccines in one injection which is called
Knowledge about Post-exposure Prophylaxis for Hepatitis B Virus among Dentists and Dental Students in Pakistan
{189} ORIGINAL RESEARCH Knowledge about Post-exposure Prophylaxis for Hepatitis B Virus among Dentists and Dental Students in Pakistan Zohaib Ahmed 1 Umber Zahra 2 Nasir Saleem 3 1,2 BDS. House Officer.
THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas 75075 (972) 867-0019
THE A, B, C S OF HEPATITIS Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas 75075 (972) 867-0019 WHAT IS HEPATITIS? Hepatitis means inflammation of the liver
Hepatitis B antenatal screening and newborn immunisation programme. Best practice guidance
Hepatitis B antenatal screening and newborn immunisation programme Best practice guidance DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Document Purpose Gateway Reference
Impact of natural boostering on long-term protection against hepatitis B after newborn (HBsAg + mothers) vaccination.
Impact of natural boostering on long-term protection against hepatitis B after newborn (HBsAg + mothers) vaccination Roznovsky Ludek Department of Infectious Diseases University Hospital Ostrava, Czech
Selective testing for hepatitis A IgG may be cost effective in vaccination candidates? Dr. Fiona Wallace
Selective testing for hepatitis A IgG may be cost effective in vaccination candidates? Dr. Fiona Wallace Northern European Conference on Travel Medicine 5, Bergen, June 2014 Acknowledgements and Declarations
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
Perinatal Hepatitis B Prevention Program COORDINATOR HANDBOOK
California Department of Public Health Perinatal Hepatitis B Prevention Program COORDINATOR HANDBOOK California Department of Public Health Immunization Branch 850 Marina Bay Parkway Building P, 2 nd Floor
Hepatitis B vaccines WHO position paper
Hepatitis B vaccines WHO position paper In accordance with its mandate to provide guidance to Member States on health policy matters, WHO is issuing a series of regularly updated position papers on vaccines
HBV Prevention Thailand Experience
HBV Prevention Thailand Experience Center of Excellence in Clinical Virology Hepatitis B immunization programe in Thailand August 1988 : Demonstrate methods of incorporating HB vaccine into EPI program
2. PROVISION OF COMBINED HEPATITIS A AND B VACCINE OR MONOVALENT HEPATITIS A OR HEPATITIS B VACCINE FOR HIGH RISK GROUPS
Guidelines for the Provision of Hepatitis A and B Vaccine to Adults in Western Australia at Risk of Acquiring these Infections by Sexual Transmission and Injecting Drug Use 1. BACKGROUND These guidelines
Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management
Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH
Epidemiology of HIV in NSW residents newly diagnosed with HIV infection up to 31 December 2013
Epidemiology of HIV in NSW residents newly diagnosed with HIV infection up to December 0 Sections Page Summary Time trend in the HIV epidemic in NSW 4 Demographics of NSW residents newly diagnosed with
Part Five Screening for Infectious diseases in pregnancy
Patient Pathway: Screening for Communicable Diseases in Pregnancy Screening to occur as early as possible during pregnancy, but can be done at any time, as soon as a woman arrives for care Provide and
Guidelines for Viral Hepatitis CTR Services
Guidelines for Viral Hepatitis CTR Services During the 2007 North Dakota Legislative Assembly, legislation that called for the creation of a viral hepatitis program was introduced and approved. The North
The University of Toledo Medical Center and its Medical Staff, Residents, Fellows, Salaried and Hourly employees
Name of Policy: Policy Number: Department: Approving Officer: Responsible Agent: Scope: Healthcare Worker Immunizations 3364-109-EH-603 Infection Prevention and Control Hospital Administration Medical
Epidemiology of Hepatitis B in Germany
Epidemiology of Hepatitis B in Germany Doris Radun, Robert Koch-Institut, Department of Infectious Disease Epidemiology, Berlin, Germany Viral Hepatitis Prevention Board Meeting Prevention of viral hepatitis
Hepatitis B: the burden. The worldwide impact of hepatitis B vaccination: A historical overview. Vaccination against Hepatitis B
The worldwide impact of hepatitis B : A historical overview Prof. Alessandro Zanetti Department of Public Health Microbiology Virology Università degli Studi di Milano, Milan, Italy Hepatitis B: the burden
HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis
HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School
Exposure. What Healthcare Personnel Need to Know
Information from the Centers for Disease Control and Prevention National Center for Infectious Diseases Divison of Healthcare Quality Promotion and Division of Viral Hepatitis For additional brochures
Hepatitis B: What Hospitals Need to Do to Protect Newborns. A resource for birthing institutions to prevent perinatal transmission
Give birth to the end of Hep B : A resource for birthing institutions to prevent perinatal transmission Prepared by the Immunization Action Coalition (IAC) Agenda I. Welcome and Agenda II. III. IV. Debra
Bloodborne Pathogens and Universal Precautions
Bloodborne Pathogens and Universal Precautions Parkway School District 2009-2010 Revised 7/30/2009 What Are Bloodborne Pathogens(BBPs) Bloodborne pathogens (BBPs) are disease causing microorganisms carried
Universal Hepatitis B vaccination in the Netherlands
Universal Hepatitis B vaccination in the Netherlands Reasons for implementation C.Richter, infectious diseases, Rijnstate hospital and member of advisory committe NHC,NL Impact of hepatitis B Two billion
Body Fluid Exposure:
Focus on CME at the University of Manitoba Focus on CME at the University of Manitoba Body Fluid Exposure: What To Do? John Sokal, MD, CFPC Presented at Bug Day 2003, Health Sciences Centre, Winnipeg (October
Molecular Diagnosis of Hepatitis B and Hepatitis D infections
Molecular Diagnosis of Hepatitis B and Hepatitis D infections Acute infection Detection of HBsAg in serum is a fundamental diagnostic marker of HBV infection HBsAg shows a strong correlation with HBV replication
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,
An overview of the OSHA standard designed to protect you from bloodborne pathogens
Bloodborne Pathogens An overview of the OSHA standard designed to protect you from bloodborne pathogens Introduction Exposure to bloodborne pathogens can occur anywhere including your workplace. Infection
The Hepatitis B virus (HBV)
The Hepatitis B virus (HBV) There are 400 million people in the world who live with chronic hepatitis B, including France. Most people don t even know they are infected. But there are several important
POST EXPOSURE PROPHYLAXI S
Departments of Infectious Diseases & Emergency Medicine POST EXPOSURE PROPHYLAXI S QUI CK GUI DE FOR EMERGENCY DEPT Adapted from Irish National PEP Guidelines and St James s Hospital GUIDE Clinic/Emergency
Infection Prevention and Control Team (IPCT) GUIDELINES FOR STAFF WHO COME INTO CONTACT WITH VARICELLA ZOSTER VIRUS (CHICKENPOX OR SHINGLES)
Infection Prevention and Control Team (IPCT) GUIDELINES FOR STAFF WHO COME INTO CONTACT WITH VARICELLA ZOSTER VIRUS (CHICKENPOX OR SHINGLES) WARNING This document is uncontrolled when printed. Check local
Offering Testing for Hepatitis B and C in Primary Care
Offering Testing for Hepatitis B and C in Primary Care Presentation 3 January 2014 Quality Education for a Healthier Scotland 1 Learning Outcomes Participants will be able to:- Undertake a pre-test discussion
Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action
Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action World Health Organization 2011. All rights reserved. The designations employed and the presentation of the material in this
ALLIED HEALTH AND NURSING PROGRAM HEALTH REQUIREMENTS
IMMUNIZATIONS: Page 1 ALLIED HEALTH AND NURSING PROGRAM HEALTH REQUIREMENTS Measles 2 MMR Vaccinations 2 Measles Vaccinations Positive antibody titer for Measles (lab report required or employer health
Invitation to Tender. Department of Health Policy Research Programme
Invitation to Tender Department of Health Policy Research Programme Chronic hepatitis B: Improving access and engagement to diagnosis and treatment pathways. Understanding why people at risk aren't being
GENERAL INFORMATION. Hepatitis B Foundation - Korean Chapter Pg. 3 www.hepb.org
GENERAL INFORMATION What is hepatitis B? Hepatitis B is the world's most common liver infection that can lead to cirrhosis and liver cancer. It is caused by the hepatitis B virus (HBV), which attacks and
University of Louisville Campus Health Services 401 East Chestnut Street Suite110 P: F:
University of Louisville Campus Health Services 401 East Chestnut Street Suite110 P: 502-852-2708 F: 502-852-0660 hlthoff@louisville.edu Training Objectives Understand the OSHA Bloodborne Pathogens Regulation
HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK
HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf
National Health Burden of CLD in Italy
National Health Burden of CLD in Italy 11,000 deaths due to liver cirrhosis or HCC in 2006 Direct costs for the National Health System for treating CLD patients: 420 M / year for hospital care 164 M /
Further information on foodborne illness is available at and
Hepatitis A Epidemiology in New Zealand The incidence of hepatitis A in New Zealand has decreased sharply since the 1960s, and currently about half the cases notified have a history of overseas travel.
Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency
Chapter 21. What Are HIV and AIDS?
Section 1 HIV and AIDS Today What Are HIV and AIDS? Human immunodeficiency virus (HIV) is the virus that primarily affects cells of the immune system and that causes AIDS. Acquired immune deficiency syndrome
Patient Information Sheet
Healthcare Worker exposure to a patient s blood What is a healthcare worker exposure? Patient Information Sheet Occasionally, health care workers come into contact with the blood or body fluids of their
DEPARTMENT OF HEALTH Rheynn Slaynt. Immunoglobulin Policy
DEPARTMENT OF HEALTH Rheynn Slaynt Immunoglobulin Policy February 2012 Contents 1. Introduction... 3 2. Rabies Immunoglobulin (RIG)... 4 2.1 Indication for use... 4 2.2 Access to the immunoglobulin...
HIV surveillance in Northern Ireland 2014
HIV surveillance in Northern Ireland 2014 Contents Page 1 Surveillance arrangements 3 2 Introduction and key points 4 3 Trend information 5 - New diagnoses Route of transmission Age and gender CD4 surveillance
Case Finding for Hepatitis B and Hepatitis C
Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center
PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN?
PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN? John T. Stutts, MD, MPH University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Gastroenterology, Hepatology
Viral Hepatitis. 2009 APHL survey report
Issues in Brief: viral hepatitis testing Association of Public Health Laboratories May Viral Hepatitis Testing 9 APHL survey report In order to characterize the role that the nation s public health laboratories
Awareness, Priorities and Action among Diabetes Educators and Adults with Diabetes
Awareness, Priorities and Action among Diabetes Educators and Adults with Diabetes A Report by the American Association of Diabetes Educators and GSK 1 I. Overview The hepatitis B virus (HBV) remains a
Managing Bloodborne Pathogens Exposures
Managing Bloodborne Pathogens Exposures House Staff Orientation 2015 Phillip F. Bressoud, MD, FACP Associate Professor of Medicine and Executive Director Campus Health Services University of Louisville
HBV DNA < monitoring interferon Rx
Hepatitis B Virus Suspected acute hepatitis >>Order: Acute Unknown hepatitis screen Suspected chronic hepatitis >>Order: Chronic unknown hepatitis screen Acute HBV or Delayed Anti HBs response after acute
BLOODBORNE PATHOGENS TRAINING
BLOODBORNE PATHOGENS TRAINING OBJECTIVES This program will outline bloodborne pathogens topics such as: Common Bloodborne Diseases and how you can be exposed A review of the UPMC Exposure Control Plan
Immunisation and Health Information for Health Care Workers and Others in At Risk Occupations
Chapter 4 Occupations 04 Information for Health Care Workers and Others in At Risk Occupations Introduction Workers in a variety of occupations may be exposed to infectious agents during their employment.
Addendum. Issue 1: Clarification of risk for infection if you get poked with a needle or cut with an instrument and the person has hepatitis B
Public Health and Primary Health Care Division Communicable Disease Control 4 th Floor, 300 Carlton St, Winnipeg, MB R3B 3M9 T 204 788-6737 F 204 948-2040 www.manitoba.ca July 4, 2012 Addendum Issue 1:
Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases
Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several